Pubblicazioni

The safety of sublingual immunotherapy, can the rare systemic reactions be prevented?

2021 - EXPERT OPINION ON DRUG SAFETY

Cavaliere, Carlo; Incorvaia, Cristoforo; Begvarfaj, Elona; Orlando, Maria Patrizia; Turchetta, Rosaria; Musacchio, Angela; Ralli, Massimo; Ciofalo, Andrea; Greco, Antonio; de Vincentiis, Marco; Masieri, Simonetta

Deprescribing in migraine

2021 - EXPERT OPINION ON DRUG SAFETY

Martelletti, P.; Luciani, M.; Spuntarelli, V.; Bentivegna, E.

Directly acting antivirals are safe and effective in HCV positive patients aged 80 years and older: a multicenter real-life study

2021 - EXPERT OPINION ON DRUG SAFETY

Pugliese, N.; Giorgini, A.; Maggi, D.; Capogreco, A.; Dibenedetto, C.; Lubrano Lobianco, F.; Dal Buono, A.; Monico, S.; Meli, R.; Battezzati, P. M.; Lleo, A.; De Santis, A.; Zuin, M.; Aghemo, A.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Reply to Dr. Hall and coworkers

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

Capecitabine in treating patients with advanced, persistent, or recurrent cervical cancer: an active and safe option?

2021 - EXPERT OPINION ON DRUG SAFETY

Tomao, F.; Caruso, G.; Musacchio, L.; Di Donato, V.; Petrella, M. C.; Verrico, M.; Tomao, S.; Benedetti Panici, P.; Muzii, L.; Palaia, I.

Long-term efficacy and safety of botulinum toxin treatment for cervical dystonia: a critical reappraisal

2021 - EXPERT OPINION ON DRUG SAFETY

Marsili, Luca; Bologna, Matteo; Jankovic, Joseph; Colosimo, Carlo

Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections

2021 - EXPERT OPINION ON DRUG SAFETY

Bassetti, Matteo; Falletta, Antonio; Cenderello, Giovanni; Giacobbe, Daniele R.; Vena, Antonio